TMO
Thermo Fisher Scientific Inc
NYSE: TMO · HEALTHCARE · DIAGNOSTICS & RESEARCH
$478.96
+2.72% today
Updated 2026-04-29
Market cap
$173.27B
P/E ratio
25.65
P/S ratio
3.83x
EPS (TTM)
$18.18
Dividend yield
0.37%
52W range
$384 – $643
Volume
2.0M
Thermo Fisher Scientific Inc (TMO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+3.2%
Last 4 quarters
Revenue YoY growth
+6.2%
Most recent quarter
EPS YoY growth
+5.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-4.8%
2026-01-29
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-01-29 | $6.57 | +1.9% | $608.02 | $578.61 | -4.8% |
| 2025-10-22 | $5.79 | +5.3% | $557.99 | $571.91 | +2.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $5.27 | $5.44 | +3.2% | $11.01B | +6.2% |
| 2025-12-31 | $6.45 | $6.57 | +1.9% | $12.21B | +7.2% |
| 2025-09-30 | $5.50 | $5.79 | +5.3% | $11.12B | +4.9% |
| 2025-06-30 | $5.23 | $5.36 | +2.5% | $10.86B | +3.0% |
| 2025-03-31 | $5.10 | $5.15 | +1.0% | $10.36B | +0.2% |
| 2024-12-31 | $5.94 | $6.10 | +2.7% | $11.39B | +4.7% |
| 2024-09-30 | $5.25 | $5.28 | +0.6% | $10.60B | +0.2% |
| 2024-06-30 | $5.12 | $5.37 | +4.9% | $10.54B | — |
| 2024-03-31 | $4.71 | $5.11 | +8.5% | $10.35B | — |
| 2023-12-31 | $5.64 | $5.67 | +0.5% | $10.89B | — |
| 2023-09-30 | $5.61 | $5.69 | +1.4% | $10.57B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $24.80 | $49.7B | +11.6% | 19 | high |
| 2027 (E) | $27.07 | $49.7B | +5.1% | 19 | high |
| 2028 (E) | $30.40 | $56.2B | +6.4% | 19 | medium |
| 2029 (E) | $33.80 | $60.1B | +7.0% | 19 | medium |
| 2030 (E) | $37.50 | $64.5B | +7.3% | 19 | medium |
Frequently asked questions
Has Thermo Fisher Scientific Inc beaten earnings estimates?
Thermo Fisher Scientific Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +3.2% over the last 4 quarters.
How does TMO stock react to earnings?
TMO stock has moved an average of -1.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Thermo Fisher Scientific Inc's revenue growth rate?
Thermo Fisher Scientific Inc reported year-over-year revenue growth of +6.2% in its most recent quarter, with EPS growing +5.6% year-over-year.
What is the expected EPS for TMO in 2026?
Analysts expect Thermo Fisher Scientific Inc to report EPS of $24.80 for fiscal year 2026, on revenue of $49.7B, based on estimates from 19 analysts.